By Ben Glickman Design Therapeutics, a clinical-stage biotechnology company, experienced a significant drop in its stock price after patients in a trial of ...
On Tuesday, Walgreens Boots Alliance, the popular pharmacy chain, revealed softer-than-anticipated earnings for the third-quarter which ended on May 31st. Although sales were ...